a possible treatment for malignant melanoma

Herpes simplex virus HSV1716 replicates in and kills melanoma tumour cells, suggesting a possible therapeutic use.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Malignant melanoma, the most serious form of skin cancer, is composed of cells derived from the foetal neural crests. Herpes simplex virus (HSV) is neurotropic virus and can therefore localise in melanoma cells. HSV variant 1716 replicates preferentially in human melanoma cell lines in vitro, causing cell lysis and death. On the basis of this mechanism, researchers from University of Glasgow suggest in a research letter to the Lancet, that HSV1716 could be used for the local treatment of human malignant melanoma.

In a preliminary study, Rona MacKie and colleagues tested the effects of intratumoral injection of HSV1716 into subcutaneous nodules of metastatic melanoma in five patients with advanced (stage 4) disease. For each patient, a test nodule was injected with103 pfu HSV1716, and a second nodule was injected with 1 ml sterile saline as a control. In one patient, flattening of previously palpable tumour nodules was seen 21 days ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution